Antibacterial activities of grepafloxacin, ciprofloxacin, ofloxacin and fleroxacin

Journal of Chemotherapy

Volumn 9, Issue 1, 1997, Pages 9-16

  Barry, A L ^a   Fuchs, P C ^a  

^a CLINICAL MICROBIOLOGY INSTITUTE   (United States)

Author keywords

ciprofloxacin; fleroxacin; grepafloxacin; ofloxacin; OPC 17116; quinolones

Indexed keywords

CIPROFLOXACIN; FLEROXACIN; GREPAFLOXACIN; OFLOXACIN;

ACINETOBACTER; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; CROSS RESISTANCE; ENTEROBACTER; ESCHERICHIA COLI; MUTANT; NONHUMAN; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STENOTROPHOMONAS MALTOPHILIA;

EID: 0030887050     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.1997.9.1.9     Document Type: Article

References (13)

1. Imada T, Miyazaki S, Nishida M, Yamaguchi K, Goto S. In vitro and in vivo antibacterial activities of a new quinolone, OPC-17116. Antimicrob Agents Chemother 1992; 36: 573-9.
2. Neu HC, Fang W, Gu J-W, Chin N-X. In vitro activity of OPC-17116. Antimicrob Agents Chemother 1992; 36: 1310-15.
3. Sader US, Erwin ME, Jones RN. In vitro activity of OPC-17116 compared to other broad-spectrum fluoroquinolones. Eur J Clin Microbiol Infect Dis 1992; 11: 372-81.
4. Wakebe H, Mitsuhashi S, Comparative in vitro activities of a new quinolone, OPC-17116, possessing potent activity against gram-positive bacteria. Antimicrob Agents Chemother 1992; 36: 2185-91.
5. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, 3rd edn; Approved Standard M7-A3, Wayne PA: National Committee for Clinical Laboratory Standards 1993.
6. National Committee for Clinical Laboratory Standards. Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria, 3rd edn; Approved Standard M11-A3, Wayne, PA: National Committee for Clinical Laboratory Standards 1993.
7. Barry AL, Fuchs PC, Jones RN, The Collaborative Antimicrobial Susceptibility Testing Group. Statistical criteria for selected quality control limits for broth microdilution susceptibility tests with 59 different antimicrobial agents. Diagn Microbiol Infect Dis 1989; 12: 413-420.
8. Sewell DL, Barry AL, Allen SD, Fuchs PC, Jorgensen JH, Tenover FC. Tentative criteria for determining the in vitro susceptibility of Haemophilus influenzae, including quality control parameters, to two fluoroquinolones (grepafloxacin and PD131628). Diagn Microbiol Infect Dis 1995; 21: 175-179.
9. National Committee for Clinical Laboratory Standards: Performance Standards for Antimicrobial Susceptibility Testing; Sixth Informational Supplement M100-S6, Wayne, PA: National Committee for Clinical Laboratory Standards 1995.
10. National Committee for Clinical Laboratory Standards. Methods for Determining Bactericidal Activity of Antimicrobial Agents; Tentative Guideline M26-T, Wayne PA: National Committee for Clinical Laboratory Standards 1992.
11. Pearson RD, Steigbigel RT, Davis HT, Chapman SW. Method of reliable determination of minimal lethal antibiotic concentrations. Antimicrob Agents Chemother 1980; 18: 699-708.
12. Barry AL. In vitro activity of the quinolones and related compounds. In: Siporin C, Heifetz CL, Donagala LM, eds. The New Generation of Quinolones. New York: Marcel Dekker, 1990: 79-105.
13. Wadsworth SJ, Kim KH, Satishchandran V, Axelrod P, Truant AL, Suh B. Development of new antibiotic resistance in methicillin-resistant but not methicillin-susceptible Staphylococcus aureus. J Antimicrob Chemother 1992; 30: 821-6.